152 related articles for article (PubMed ID: 36178608)
1. Body mass index and additional risk factors for cancer in adults with cystic fibrosis.
Knotts RM; Jin Z; Doyle JB; Keating C; DiMango E; Abrams JA
Cancer Causes Control; 2022 Dec; 33(12):1445-1451. PubMed ID: 36178608
[TBL] [Abstract][Full Text] [Related]
2. Nutritional status and lung function in children with pancreatic-sufficient cystic fibrosis.
Madde A; Okoniewski W; Sanders DB; Ren CL; Weiner DJ; Forno E
J Cyst Fibros; 2022 Sep; 21(5):769-776. PubMed ID: 34972650
[TBL] [Abstract][Full Text] [Related]
3. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
4. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
[TBL] [Abstract][Full Text] [Related]
5. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
[TBL] [Abstract][Full Text] [Related]
7. Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort study.
Collaco JM; Blackman SM; Raraigh KS; Morrow CB; Cutting GR; Paranjape SM
BMC Pulm Med; 2014 Oct; 14():159. PubMed ID: 25287419
[TBL] [Abstract][Full Text] [Related]
8. Serum zinc concentration in cystic fibrosis patients with CFTR I1234V mutation associated with pancreatic sufficiency.
AbdulWahab A; Abushahin A; Allangawi M; Chandra P; Abdel Rahman MO; Soliman A
Clin Respir J; 2017 May; 11(3):305-310. PubMed ID: 26096753
[TBL] [Abstract][Full Text] [Related]
9. [Italian Cystic Fibrosis Register - Report 2010].
Amato A; Ferrigno L; Salvatore M; Toccaceli V;
Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
[TBL] [Abstract][Full Text] [Related]
10. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
11. Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.
Baldwin C; Zerofsky M; Sathe M; Troendle DM; Perito ER
Pancreas; 2019 Aug; 48(7):888-893. PubMed ID: 31268981
[TBL] [Abstract][Full Text] [Related]
12. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis.
Modolell I; Alvarez A; Guarner L; De Gracia J; Malagelada JR
Pancreas; 2001 May; 22(4):395-9. PubMed ID: 11345141
[TBL] [Abstract][Full Text] [Related]
14. Novel CFTR mutations in a Korean infant with cystic fibrosis and pancreatic insufficiency.
Choe YJ; Ko JS; Seo JK; Han JJ; Shim JO; Koh YY; Lee R; Ki CS; Kim JW; Kim JH
J Korean Med Sci; 2010 Jan; 25(1):163-5. PubMed ID: 20052365
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Status and Risk of Cystic Fibrosis-Related Diabetes: A Retrospective Single Center Cohort Study.
Peng Y; Wu M; Alvarez JA; Tangpricha V
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836301
[TBL] [Abstract][Full Text] [Related]
16. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
17. The determinants of survival among adults with cystic fibrosis-a cohort study.
Durda-Masny M; Goździk-Spychalska J; John A; Czaiński W; Stróżewska W; Pawłowska N; Wlizło J; Batura-Gabryel H; Szwed A
J Physiol Anthropol; 2021 Nov; 40(1):19. PubMed ID: 34749804
[TBL] [Abstract][Full Text] [Related]
18. Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany.
Dittrich AS; Dumke M; Kapl F; Schneider P; Wege S; Gräber S; Stahl M; Herth FJ; Naehrlich L; Mall MA; Sommerburg O;
Respiration; 2023; 102(5):1. PubMed ID: 37062281
[TBL] [Abstract][Full Text] [Related]
19. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
20. [Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2022; 46(4 Suppl 2):1-38. PubMed ID: 36102313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
